ARCHIVES

Early-Stage HER2+ Breast Cancer Patients Are At Significant Risk Of Recurrence

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

Afinitor and Exemestane More Than Doubles PFS, Reduces Progression Risk by 57 Percent

September 30, 2011

ACS Initiates Cage In Approach to Study Of alternative Methods

June 18, 1993

NIH, Myriad Talked About CRADA, Didn’t Agree, Varmus Writes

November 4, 1994

Bill Promotes Awareness Of Pediatric Cancer Research.

September 22, 2000

NCI Puts Aside Fear Of Brockovich Factor To Open New Web Site On Mortality Data.

April 20, 2001

Food & Water Inc. Launches ‘Cancer Prevention Campaign’

May 1, 1992